Tuberculosis in the course of sarcoidosis treatment: Is genotyping necessary for personalized therapy?

Expert Review of Clinical Immunology

Volumn 9, Issue 4, 2013, Pages 349-360

  Dubaniewicz, Anna ^a   Zimmermann, Agnieszka ^a   Dudziak, Maria ^a   Typiak, Marlena ^a   Skotarczak, Monika ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

HLA genotyping; personalized therapy; sarcoidosis; tuberculosis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HYDROXYCHLOROQUINE; INTERLEUKIN 1BETA; METHOTREXATE; MYCOBACTERIUM ANTIGEN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PENTOXIFYLLINE; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

AFRICAN AMERICAN; ALLELE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ETHNIC GROUP; GENETIC PREDISPOSITION; GENOTYPE; HLA SYSTEM; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFILTRATE; MYCOBACTERIUM TUBERCULOSIS; PERSONALIZED MEDICINE; REVIEW; SARCOIDOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADRENAL CORTEX HORMONES; ANIMALS; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; INDIVIDUALIZED MEDICINE; MYCOBACTERIUM; POLYMORPHISM, GENETIC; SARCOIDOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875923339     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.13.8     Document Type: Review

References (80)

1. American Thoracic Society. Statement on sarcoidosis. Am. J. Respir. Crit. Care Med. 160, 736-755 (1999
2. Brownell I, Ramírez-Valle F, Sanchez M, Prystowsky S. Evidence for mycobacteria in sarcoidosis. Am. J. Respir. Cell Mol. Biol. 45(5), 899-905 (2011
3. Dubaniewicz A. Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun. Rev. 9(6), 419-424 (2010
4. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Sarcoidosis and tuberculosis: The same disease with different manifestations or similar manifestations of different disorders. Curr. Opin. Pulm. Med. 18(5), 506-516 (2012
5. Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A et al. Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J. Clin. Microbiol. 44(9), 3448-3451 (2006
6. Dubaniewicz A, Kämpfer S, Singh M. Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis. Tuberculosis (Edinb.) 86(1), 60-67 (2006
7. Oswald-Richter K, Sato H, Hajizadeh R et al. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1.*1101. J. Clin. Immunol. 30(1), 157-166 (2010
8. Ang SC, Moscovic EA. Cross-reactive and species specific Mycobacterium tuberculosis antigens in the immunoprofile of Schaumann bodies: A major clue to the etiology of sarcoidosis. Histol. Histopathol. 11(1), 125-134 (1996
9. Dubaniewicz A, Holownia A, Kalinowski L, Wybieralska M, Dobrucki IT, Singh M. Is mycobacterial heat shock protein 16 kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen? Hum. Immunol. 74(1), 45-51 (2013
10. Dubaniewicz A, Wybieralska M, Rogoza K et al. Phagocytosis by blood monocytes in differentiation between sarcoidosis and tuberculosis. Eur. Respir. J. 40(56), S485 (2012
11. Dubaniewicz A, Szadurska M, Wybieralska M et al. Fc?R and CR on blood monocytes in differentiation between sarcoidosis and tuberculosis. Eur. Respir. J. 40(56), S484 (2012
12. Dubaniewicz A, Typiak M, Wybieralska M et al. Changed phagocytic activity and pattern of Fc? and complement receptors on blood monocytes in sarcoidosis. Hum. Immunol. 73(8), 788-794 (2012
13. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, Mysliwski A. Comparative analysis of mycobacterial heat shock proteins-induced apoptosis of peripheral blood mononuclear cells in sarcoidosis and tuberculosis. J. Clin. Immunol. 26(3), 243-250 (2006
14. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, Mysliwski A. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: Comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 12(3), 346-354 (2007
15. Gupta D, Agarwal R, Aggarwal AN, Verma I. Immune responses to mycobacterial antigens in sarcoidosis: A systematic review. Indian J. Chest Dis. Allied Sci. 53(1), 41-49 (2011
16. Raja A, Uma Devi KR, Ramalingam B, Brennan PJ. Immunoglobulin G, A, and M responses in serum and circulating immune complexes elicited by the 16-kilodalton antigen of Mycobacterium tuberculosis. Clin. Diagn. Lab. Immunol. 9(2), 308-312 (2002
17. Jee B, Katoch VM, Awasthi SK. Dissection of relationship between small heat shock proteins and mycobacterial diseases. Indian J. Lepr. 80(3), 231-245 (2008
18. Cunningham AF, Spreadbury CL. Mycobacterial stationary phase induced by low oxygen tension: Cell wall thickening and localization of the 16-kilodalton a-crystallin homolog. J. Bacteriol. 180(4), 801-808 (1998
19. Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13(11), 908-914 (1994
20. Simpson RM, Zhu YQ, Hickey MJ et al. The 16-kDa a-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc. Natl Acad. Sci. USA 95, 9578-9583 (1998
21. Voskuil MI, Schnappinger D, Visconti KC et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198(5), 705-713 (2003
22. Garbe TR, Hibler NS, Deretic V. Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: Induction of the 16-kilodalton a-crystallin homolog by exposure to nitric oxide donors. Infect. Immun. 67(1), 460-465 (1999
23. Booth RJ, Williams DL, Moudgil KD et al. Homologs of Mycobacterium leprae 18-kilodalton and Mycobacterium tuberculosis 19-kilodalton antigens in other mycobacteria. Infect. Immun. 61(4), 1509-1515 (1993
24. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 11(5), 343-354 (2011
25. Dubaniewicz A, Dubaniewicz A. Human Leukocyte antigens class I and class II: Associations and distribution in different ethnic groups of patients with pulmonary tuberculosis. Curr. Respir. Med. Rev. 1, 117-121 (2005
26. Dubaniewicz A, Szczerkowska Z, Hoppe A. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clin. Proc. 78(4), 436-442 (2003
27. Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: Preliminary study. Sarcoidosis Vasc. Diffuse Lung Dis. 23(3), 180-189 (2006
28. Dubaniewicz A, Moszkowska G, Szczerkowska Z. Frequency of DRB1-DQB1 two-locus haplotypes in tuberculosis: Preliminary report. Tuberculosis (Edinb.) 85(4), 259-267 (2005
29. Sato H, Woodhead FA, Ahmad T et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum. Mol. Genet. 19(20), 4100-4111 (2010
30. Yim JJ, Selvaraj P. Genetic susceptibility in tuberculosis. Respirology 15(2), 241-256 (2010
31. Morgenthau AS, Iannuzzi MC. Recent advances in sarcoidosis. Chest 139(1), 174-182 (2011
32. Goljan A, Puscinska E, Sankowska M, Zielinski J. [Polymorphism of histocompatibility class II antigens coded with the DRB gene in in familial sarcoidosis in Poland]. Pneumonol. Alergol. Pol. 68(11-12), 533-544 (2000
33. Kurian SM, Selvaraj P, Reetha AM, Charles N, Narayanan PR. HLA-DR phenotypes and lymphocyte response to M. tuberculosis antigens in cures spinal tuberculosis patients and their contacts. Indian. J. Tuberc. 51, 71-75 (2004
34. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am. J. Respir. Crit. Care Med. 169(6), 696-702 (2004
35. Idali F, Wikén M, Wahlström J et al. Reduced Th1 response in the lungs of HLA-DRB1.*0301 patients with pulmonary sarcoidosis. Eur. Respir. J. 27(3), 451-459 (2006
36. Khomenko AG, Litvinov VI, Chukanova VP, Pospelov LE. Tuberculosis in patients with various HLA phenotypes. Tubercle 71(3), 187-192 (1990
37. Mrazek F, Holla LI, Hutyrova B et al. Association of tumour necrosis factor-a, lymphotoxin-a and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 65(2), 163-171 (2005
38. Swider C, Schnittger L, Bogunia-Kubik K et al. TNF-a and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur. Cytokine Netw. 10(2), 143-146 (1999
39. Grosser M, Luther T, Fuessel M, Bickhardt J, Magdolen V, Baretton G Clinical course of sarcoidosis in dependence on HLADRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc. Diffuse Lung Dis. 22(1), 66-74 (2005
40. Papadopoulos KI, Wassmuth R, Sponsel T et al. Sarcoidosis and autoimmunity: Evidence of differential associations with HLA class II markers. Int. J. Endocrinol. Metab. 4, 13-18 (2006
41. Rossman MD, Thompson B, Frederick M et al.; ACCESS Group. HLA-DRB1.*1101: A significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 73(4), 720-735 (2003
42. Foley PJ, McGrath DS, Puscinska E et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell Mol. Biol. 25(3), 272-277 (2001
43. Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am. J. Respir. Cell Mol. Biol. 29(2), 225-231 (2003
44. Ishihara M, Ohno S, Ishida T et al. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 43(4), 238-241 (1994
45. Rutherford RM, Brutsche MH, Kearns M, Bourke M, Stevens F, Gilmartin JJ. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 21(3), 191-198 (2004
46. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 156(5), 1601-1605 (1997
47. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am. J. Respir. Crit. Care Med. 167(9), 1225-1231 (2003
48. Goldfeld AE, Delgado JC, Thim S et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 279(3), 226-228 (1998
49. Vejbaesya S, Chierakul N, Luangtrakool K, Srinak D, Stephens HA. Associations of HLA class II alleles with pulmonary tuberculosis in Thais. Eur. J. Immunogenet. 29(5), 431-434 (2002
50. Terán-Escandón D, Terán-Ortiz L, Camarena-Olvera A et al. Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: Molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients. Chest 115(2), 428-433 (1999
51. Rani R, Mukherjee R, Stastny P. Diversity of HLA-DR2 in North Indians: The changed scenario after the discovery of DRB1.*1506. Tissue Antigens 52(2), 147-152 (1998
52. Mehra NK, Rajalingam R, Mitra DK, Taneja V, Giphart MJ. Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians. Int. J. Lepr. Other Mycobact. Dis. 63(2), 241-248 (1995
53. Ravikumar M, Dheenadhayalan V, Rajaram K et al. Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India. Tuber. Lung Dis. 79(5), 309-317 (1999
54. Sriram U, Selvaraj P, Kurian SM, Reetha AM, Narayanan PR. HLA-DR2 subtypes & immune responses in pulmonary tuberculosis. Indian J. Med. Res. 113, 117-124 (2001
55. Hwang CH, Khan S, Ende N, Mangura BT, Reichman LB, Chou J. The HLA-A, -B, and -DR phenotypes and tuberculosis. Am. Rev. Respir. Dis. 132(2), 382-385 (1985
56. Wang J, Song C, Wang S. [Association of HLA-DRB1 genes with pulmonary tuberculosis.] Zhonghua Jie. He. He. Xi. Za. Zhi. 24, 302-305 (2001
57. Grunewald J. HLA associations and Löfgren's syndrome. Expert Rev. Clin. Immunol. 8(1), 55-62 (2012
58. Dubaniewicz A, Jamieson SE, Dubaniewicz-Wybieralska M, Fakiola M, Nancy Miller E, Blackwell JM. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur. J. Hum. Genet. 13(7), 829-834 (2005
59. Maertzdorf J, Weiner J 3rd, Mollenkopf HJ et al.; TBornotTB Network. Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc. Natl Acad. Sci. USA 109(20), 7853-7858 (2012
60. Dubaniewicz A, Zimmermann A, Smigielska M et al. Sarcoidosis and tuberculosis: A connection to the human leukocyte antigen system. Adv. Exp. Med. Biol. 756, 229-237 (2013
61. Plesner A, Greenbaum CJ, Gaur LK, Ernst RK, Lernmark A. Macrophages from high-risk HLA-DQB1.*0201/.*0302 type 1 diabetes mellitus patients are hypersensitive to lipopolysaccharide stimulation. Scand. J. Immunol. 56(5), 522-529 (2002
62. Price P, Witt C, Allcock R et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167, 257-274 (1999
63. Sidney J, del Guercio MF, Southwood S, Sette A. The HLA molecules DQA1.*0501/ B1.*0201 and DQA1.*0301/B1.*0302 share an extensive overlap in peptide binding specificity. J. Immunol. 169(9), 5098-5108 (2002
64. Arlehamn CS, Sidney J, Henderson R et al. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J. Immunol. 188(10), 5020-5031 (2012
65. Dubaniewicz A, Dubaniewicz A, Dubaniewicz A, Moszkowska G. DQA1.*03011 allele: Protective or an adverse effect on the development of sarcoidosis; preliminary study. Respir. Med. 101(10), 2213-2216 (2007
66. Livnat S, Madden KS, Felten DL, Felten SY. Regulation of the immune system by sympathetic neural mechanisms. Prog. Neuropsychopharmacol. Biol. Psychiatry 11(2-3), 145-152 (1987
67. Messerli FH, Grossman E. The calcium antagonist controversy: A posthumous commentary. Am. J. Cardiol. 82(9B), 35R-39R (1998
68. Steffens S, Mach F. Anti-inflammatory properties of statins. Semin. Vasc. Med. 4(4), 417-422 (2004
69. Mach F. Immunosuppressive effects of statins. Atheroscler. Suppl. 3(1), 17-20 (2002
70. Lazar CA, Culver DA. Treatment of sarcoidosis. Semin. Respir. Crit. Care Med. 31(4), 501-518 (2010
71. Judson MA. Sarcoidosis: Clinical presentation, diagnosis, and approach to treatment. Am. J. Med. Sci. 335(1), 26-33 (2008
72. Hostettler KE, Studler U, Tamm M, Brutsche MH. Long-term treatment with infliximab in patients with sarcoidosis. Respiration. 83(3), 218-224 (2012
73. Zimmermann A, Dubaniewicz A, Slominski JM. Pharmacotherapy for sarcoidosis: An example of an off-label procedure. Adv. Exp. Med. Biol. 755, 251-256 (2013
74. Martin WJ 2nd, Iannuzzi MC, Gail DB, Peavy HH. Future directions in sarcoidosis research: Summary of an NHLBI working group. Am. J. Respir. Crit. Care Med. 170(5), 567-571 (2004
75. Sester M, Sotgiu G, Lange C et al. Interferon-? release assays for the diagnosis of active tuberculosis: A systematic review and meta-analysis. Eur. Respir. J. 37(1), 100-111 (2011
76. Gupta D, Kumar S, Aggarwal AN, Verma I, Agarwal R. Interferon ? release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc. Diffuse Lung Dis. 28(2), 95-101 (2011
77. Milman N, Søborg B, Svendsen CB, Andersen AB. Quantiferon test for tuberculosis screening in sarcoidosis patients. Scand. J. Infect. Dis. 43(9), 728-735 (2011
78. Grunewald J, Eklund A. Löfgren's syndrome: human leukocyte antigen strongly influences the disease course. Am. J. Respir. Crit. Care Med. 179(4), 307-312 (2009
79. Tobin DM, Roca FJ, Oh SF et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148(3), 434-446 (2012
80. Leidl L, Mayanja-Kizza H, Sotgiu G et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur. Respir. J. 35(3), 619-626 (2010